Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 

Keywords

2025-09-18 08:03:55| The Economic Times

Rashidun Bokhari, a prominent figure in Queens' Bangladeshi community, was convicted of wire fraud for embezzling over $1 million from fellow immigrants. He exploited their shared background, promising real estate deals that never materialized, leaving victims financially devastated. The Bokhari's flamboyant lifestyle, funded by the fraud, is now under scrutiny as the government seeks restitution through liens on their properties.


Category: News and Media

 

2025-09-18 07:58:44| The Economic Times

Railway stocks have seen gains recently. Some experts believe it's a short-term bounce due to previous underperformance. Others point to order wins as a positive sign. Concerns remain about execution delays and high valuations. Government spending direction is also a factor. Railtel, RVNL and Jupiter Wagons recently received orders. Investors should approach the sector with caution.


Category: News and Media

 

2025-09-18 07:44:52| The Economic Times

Euro Pratik Sales IPO: The grey market premium on Euro Pratik Sales IPO has fallen further, easing to 0.4% above the 247 issue price, down from 2.5% on Day 2.


Category: News and Media

 

2025-09-18 07:12:01| The Economic Times

VMS TMT's Rs 149 crore IPO has garnered significant investor interest, with an overall subscription of 12.49 times on its second day, driven by strong NII participation. The IPO shares are trading at a 17% premium in the grey market, reflecting positive market sentiment. Proceeds from the IPO will be used to repay borrowings and for general corporate purposes.


Category: News and Media

 

2025-09-18 07:06:19| The Economic Times

Shares of Biocon Ltd rose 2% to Rs 361.25 on the BSE after its subsidiary, Biocon Biologics, received U.S. FDA approval for two denosumab biosimilars, Bosaya and Aukelso. The regulator also granted provisional interchangeability for both drugs, allowing pharmacy-level substitution, which could support broader market adoption and strengthen Biocons position in the biosimilars segment.


Category: News and Media

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »

Privacy policy . Copyright . Contact form .